Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/03/2012US20120107377 Particulate composition and pharmaceutical composition containing the same
05/03/2012US20120107376 Method for improving bioavailability of latanoprost
05/03/2012US20120107375 Antimicrobial material
05/03/2012US20120107374 Coenzyme q10-containing composition
05/03/2012US20120107373 Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use
05/03/2012US20120107372 Recombinant gelatins
05/03/2012US20120107371 Stimuli-responsive systems for controlled drug delivery
05/03/2012US20120107370 Methods and compositions for treating hiv-associated diarrhea
05/03/2012US20120107369 Polymers and Hydrogels
05/03/2012US20120107368 Compressible tablet material having an oil-containing active substance, tablet as well as method and device for the production thereof
05/03/2012US20120107367 Site-Specific Intestinal Delivery of Adsorbents, Alone or in Combination with Degrading Molecules
05/03/2012US20120107366 Block Copolymer Systems and Their Use in Medical Devices
05/03/2012US20120107365 Films and particles
05/03/2012US20120107250 Abuse-proofed dosage form
05/03/2012US20120107242 Nucleic acid-mediated shape control of nanoparticles for biomedical applications
05/03/2012US20120107241 Particles for Inhalation Having Sustained Release Properties
05/03/2012US20120104047 Composition for Relief of Insect Bites and Stings and Apparatus and Method for Its Delivery
05/03/2012DE102010049708A1 Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe Oral pharmaceutical film formulation for bitter tasting drugs
05/03/2012DE102010049706A1 Herstellung orodispersibler Filme Production orodispersibler Movies
05/03/2012CA2852210A1 Composition and method for treating wounds
05/03/2012CA2818931A1 Process for analyzing and establishing dosage size in an ingestible film
05/03/2012CA2816564A1 Inflammatory disease
05/03/2012CA2816420A1 Compositions of (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol
05/03/2012CA2816418A1 Novel formulations of water-insoluble chemical compounds and methods of using a formulation of compound fl118 for cancer therapy
05/03/2012CA2816171A1 Liposomal drug composition containing a polymeric guanidine derivative
05/03/2012CA2816119A1 Ternary mixture formulations
05/03/2012CA2816104A1 Deuterium enriched rasagiline
05/03/2012CA2816052A1 Liquid formulations of long acting interferon alpha conjugate
05/03/2012CA2815960A1 Tau imaging probe
05/03/2012CA2814951A1 Hypersulfated disaccharides to treat elastase related disorders
05/03/2012CA2814888A1 Medicinal product comprising hydromorphone, with improved shelf-life
05/03/2012CA2814411A1 Polymorphs of febuxostat
05/03/2012CA2814230A1 Formulations and methods for attenuating respiratory depression induced by opioid overdose
05/03/2012CA2813833A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties
05/03/2012CA2811805A1 Solid dispersions containing an apoptosis-inducing agent
05/02/2012EP2446929A1 Microvesicles derived from atheroprotective endothelial cells for the treatment and prevention of atherosclerotic diseases
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP2446882A1 Medicament with improved storage stability containing the active ingredient hydromorphone
05/02/2012EP2446881A1 Orally Dissolving Films
05/02/2012EP2446880A1 Film-coated tablets containing drospirenone as active agent and a method for the preparation thereof
05/02/2012EP2446879A2 Pharmaceutical composition containing carboxylosartan and a production method therefor
05/02/2012EP2446878A1 Ketorolac tromethamine compositions for treating or preventing ocular pain
05/02/2012EP2446877A1 Modified starch derivative-based matrix for colon targeting
05/02/2012EP2446031A1 Stabilizing alkylglycoside compositions and methods thereof
05/02/2012EP2445588A2 Topical formulation containing a tetracycline and a method of treating skin infections using the same
05/02/2012EP2445571A1 Solid drug tablets for implantable drug delivery devices
05/02/2012EP2445570A1 Implantable drug delivery devices and methods of making the same
05/02/2012EP2445544A1 Cannula assembly for co-delivery of medicaments
05/02/2012EP2445532A1 Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
05/02/2012EP2445499A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
05/02/2012EP2445498A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
05/02/2012EP2445496A2 Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
05/02/2012EP2445493A1 Topical composition containing naproxen
05/02/2012EP2445492A1 Topical composition containing ibuprofen
05/02/2012EP2445487A2 Controlled release formulations
05/02/2012EP2445486A2 Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
05/02/2012EP2445485A1 Chewable drug
05/02/2012EP2445484A1 Aprepitant in the form of a solid solution
05/02/2012EP2445483A2 Topical compositions and methods for wound care
05/02/2012EP2445482A1 Method for preparing an enriched igg composition from plasma
05/02/2012EP2445481A2 Methods and devices for delivery of pharmaceutical agents within orifices of the body
05/02/2012EP2445472A1 Composition for cosmetic, pharmaceutical or dietary applications
05/02/2012EP2445344A1 Method for treating a patient in need of aspirin therapy
05/02/2012EP2242482B1 Anti - retroviral combination
05/02/2012EP2131674B1 Allergen-free, protein-free or at least dairy free powdered nutritional compositions and the use thereof in food products
05/02/2012EP2058010B1 Pharmaceutical composition
05/02/2012EP2026832B1 Combination of interferon-beta and a cladribine regimen for treating multiple sclerosis
05/02/2012EP1987082B1 Subtituted organopolysiloxanes and use thereof
05/02/2012EP1945217B1 Combinations comprising a vegf receptor inhibitor and a penetration enhancer
05/02/2012EP1901715B1 Spray-drying process for producing a dry carnitine powder or granulate
05/02/2012EP1829545B1 Prostaglandin f2 alpha derivative containing products
05/02/2012EP1733720B1 Composition comprising reduced-form coenzyme q10 and carotenoid compound
05/02/2012EP1666020B1 Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use
05/02/2012EP1638609B1 Method for the preparation of molecular complexes
05/02/2012EP1581193B1 Biodegradable ocular implant
05/02/2012EP1549246B1 Antibiotic micropheres for treatment of infections and osteomyelitis
05/02/2012EP1531888B1 Infusion pump for the dosed administration of a medicinal liquid
05/02/2012EP1528933B1 Pharmaceutical anti-tnf-alpha antibody formulation
05/02/2012EP1492511B3 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1418893B1 Compositions and techniques for localized therapy of restenosis
05/02/2012EP1399133B2 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same
05/02/2012EP1185248B1 Supercritical fluid-assisted nebulization and bubble drying
05/02/2012CN202207326U Ventilated acupoint stick
05/02/2012CN1404398B Improved DNA vaccines for production-type animals
05/02/2012CN102438978A Polyamine derivatives
05/02/2012CN102438686A Device for intranasal administration
05/02/2012CN102438647A Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
05/02/2012CN102438645A Therapeutic modulation of vaginal epithelium boundary lubrication
05/02/2012CN102438627A A novel formulation of meloxicam
05/02/2012CN102438623A Solid preparation containing npy y5 receptor antagonist
05/02/2012CN102438621A A novel formulation of metaxalone
05/02/2012CN102438619A Prenylated bisphosphonates as anti-tuberculosis agents
05/02/2012CN102438610A A novel formulation of diclofenac
05/02/2012CN102438602A An improved dry powder drug delivery system
05/02/2012CN102438601A Electrostatically charged multi-acting nasal application, product and method
05/02/2012CN102438600A Method for improving the dissolution profile of a biologically active material
05/02/2012CN102438599A Nutritional composition and method for control of diabetes by lowering of the blood sugar level
05/02/2012CN102438598A Multi-layer tablet comprising effervescent layer
05/02/2012CN102438597A A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 2991